Primary Site >> Colorectal Cancer
Gene >> RGS5
|
|
|---|---|
|
Ref: Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer. PMID: 25069475 |
Ref: Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen. PMID: 26974145 |